chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ITCHY AT SITE OF INJECTION, REDNESS, HOT TO THE TOUCH AND HARD
Localized redness/rash to left deltoid 3 days after vaccine administration. Reaction to imms w/redness/swollenness/hot. Immunization was given 3 days ago. Area of imms is red and warm. No discharge. No f/n/v. Area is improved since yesterday and is less painful. Still 6/10 today.
Starting in April 2021, noticed that my Creatinine levels started to increase by 0.1 per month following my second dose of the Moderna vaccine in February 2021.  Subsequent labs through October continued to show increasing Creatine levels.  Creatinine levels rose from 2.33 in March 2021  to 3.1 in October 2021.  Then, in November 2021, my Creatinine levels dropped to 2.6.  Then, after my 3rd booster dose of Moderna in December 2021, my Creatine Levels began to rise again to 2.9 in February 2022,
Case number PHEH2017US000576, is initial spontaneous report received from consumer on 03 Jan 2017. This report refers to a 73 year old female patient. Medical history and concomitant medication was not reported. The patient was vaccinated with single dose of FLUAD (batch number: 166101) intramuscular into left arm at dose of 0.5 ml on 22 Nov 2016. On the same day, the patient had consistently hurt (uncomfortable) where the vaccine was given. This was making her nervous. She was heart medication patient too. The outcome of the events was reported as unknown. The seriousness and causality of the events was not reported.
temp elevated day of vax, down next day, T104.1 today had spell of shaking turned gray in color & lips turned purple per babysitter;time of visit baby face flushed, ears red, nose runny;referred to MD;
Patient received his flu shot at a clinic, his place of work. About 20 minutes later he came up saying he  had anxiety and  shortness of breath. Took his blood pressure and pulse when he initially came up (BP: 132/89 and pulse was 132) then we took his pulse after we had him sit down and gave him water and 12.5ml of BENADRYL. We took his pulse before he left and it was 112. I followed up with him again a couple of weeks later and he said he was fine, hadn't had any of the symptoms he had experienced that day again or any other possible symptoms.
itching at the injection site; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization, benralizumab (FASENRA), via an unspecified route of administration from an unspecified date to an unspecified date at unknown dose for an unspecified indication.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced itching at the injection site (non-serious) on an unspecified date with outcome of unknown. The action taken in response to the event for benralizumab was unknown. Caller was a consumer, asking if it was too soon after receiving benralizumab to get the covid vaccine.  Information on lot/batch number has been requested.
Coughing since received booster; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing since received booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced COUGH (Coughing since received booster). At the time of the report, COUGH (Coughing since received booster) outcome was unknown.            NO concomitants were provided. No treatment is reported. requested for follow-up since incomplete patient and dosage details provided.
It was reported in a newspaper article that an 18 year old female who was vaccinated with GARDASIL (dose, route and lot numbers unspecified). On an unspecified date after the patient received the vaccine, she began having seizures in the spring 2008 (approximately March 2008), often more than once a day. Her body, her brain, her stomach ache, her hair fell out, her gums bleed, her legs bruise, her hands shake with tremors. The patient "didn't die, but there are days when death seems to hover nearby". At the time of the report, the outcome of the patient was unknown. This is one of several reports received from the same source. No further information is available.
Several days (3+) of fever, chills, sweats, fatigue. Sore arm at injection site.
Pain in left shoulder, stiff neck, low grade fever.  Sore muscles in left shoulder, back and neck. No treatment. Pain and stiffness still exists (3rd day). My wife's onset and symptoms are similar. We both received the vaccine 9/27/2012.
Left deltoid red, warm to touch and swollen to the size of an egg. Pt stated area was also burning. Pt given ice packs and told to take Tylenol or Motrin. If symptoms persisted or got worse to return to clinic or Emergency Department.
PT RECEIVED H1N1 VACCINE TWICE. FIRST INJECTION GIVEN ON 10/26/09 AND SECOND INJECTION GIVEN ON 11/03/09.
G62.9 PERIPHERAL NEUROPATHY 12/6/2021 PANCREATIC MASS I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 12/28/2021 PANCREATIC MASS I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 1/6/2022 PANCREATIC MASS G62.9 PERIPHERAL NEUROPATHY 12/6/2021 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 12/28/2021 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 1/6/2022 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN
This spontaneous report has been received from an unspecified reporter and refers to 4 patients of unknown age and gender. There was no information about the patients' concomitant therapies and medical history provided. The patients' concurrent conditions included wards. On unknown dates, the patients administered unidentified Merck HPV vaccine (name and lot number not provided), while they were all over the 26 years of age. On unknown dates, after the receiving the vaccines, all the patients recovered from the warts (reported as the wards "went away"). No product quality complaint was involved. Additional information is not expected because there was no consent to contact the patients' physician.
The pt developed a fever, headache and vomiting 24 hours post vax. He was ill for 2 days.
Information has been received from a nurse practitioner concerning a 19 year old female patient with no medical history and no allergies reported who on 02-MAY-2008 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (Lot # 660387/1967U).  Concomitant therapy included hormonal contraceptives (unspecified).  On 03-MAY-2008, approximately 24 hours after the vaccination, the patient developed a vesicular rash on her lower lip and on the tip of her tongue.  The patient was seen in the office on 05-MAY-2008.  No diagnostic laboratory testing was performed.  At the time of this report, the patient's outcome was not recovered.  No product quality complaint was involved.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/13/2008.  Initial and follow up information has been received from a nurse practitioner concerning a 13 year old female patient with no medical history and no allergies reported who on 03-MAY-2008 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (Lot # 560387/1967U).  Concomitant therapy included hormonal contraceptives (unspecified).  On 03-MAY-2008, approximately 24 hours after the vaccination, the patient awoke with papules and vesicles on the inside of her upper and lower lip and on the tip of her tongue.  No reported difficulty breathing, and no reaction at the vaccination site.  On 05-MAY-2008, two days after the incident.  The patient was seen in the office.  The symptoms were present (papules and vesicles).  The nurse practitioner spoke with department who advised the nurse to advise the patient not to complete the series of vaccinations.  The nurse then advised the patient.  No diagnostic laboratory testing was performed.  At the time of this report, the patient's outcome was recovered.  No product quality complaint was involved.  Additional information has been requested.
One month after vaccine given mother presented to the office with report that 6-7 days after the shots (MMR and Varicella) that the pt was moody, unresponsive like he was staring off into space.  He wouldn't look at anyone, in the church nursery he stood up in the same spot and did not move, even when other children bumped into him, like he was in a "trance"  He behaved like this for 3-4 days then started to act more normally again.  He would also say the same sound over and over.  He is doing some toe walking too.  Mom didn't call me sooner because she and the dad weren't sure what the cause was.
2 Weeks after second injection, I awoke at 2:30 AM with serious Vertigo. For the next 3 1/2 weeks, I suffered from loss of equilibrium.   Had BVVP treatments. Helped but still have some mild bouts.
OFF LABEL USE; INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-smoker, non-alcohol user (cannot drink alcohol d/t hydrogenase), and drug allergy (Aspirin). The patient did not have any drug abuse/illicit drug use. The patient previously received initial dose of covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin and batch number were not reported, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with initial dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received first booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin and batch number were not reported, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2). The patient received second booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 3) (suspension for injection, route of admin and batch number were not reported, expiry: unknown) dose was not reported, 1 total administered on APR-2022 to left arm for prophylactic vaccination which was an off label use and inappropriate schedule of vaccine administration (dose number in series 3). The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  The reporter stated that, she and her husband also received second JNJ Covid-19 booster dose within the last week and had no side effects to report. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the off label use and inappropriate schedule of vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20220441407.
IMMUNIZATION WAS GIVEN INTRAMUSCULARLY IN PT LEFT ARM. PT ON ELIQUIS. LARGE RISE FORMED ON INSIDE OF LEFT ARM. PT WENT TO DOCTOR 4 OR 5 DAYS LATER AD DOCTOR SAID IT WAS FROM THE FLU SHOT THAT WE PROBABLY NICKED A VEIN WHEN IT WAS GIVEN. PT CAME BACK TO REPORT TO PHARMACY
she experienced migraine auras: seeing things that aren't there.; had dizziness; saw black dots; This is a spontaneous report from a contactable consumer. This 68-years old female patient reported for herself that.  A 68-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. Medical history included migraine from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took first dose of BNT162B2 for COVID-19 immunization. Caller is a 68-year-old female who received the second dose of the Pfizer Covid 19 vaccine on 06Feb2021. She states she is doing well. Patient had pneumonia vaccines in the past that she didn't develop antibodies to and had to have additional doses of the vaccine. Is there an antibody test available to see if she have antibodies from the Pfizer Covid 19 vaccine. She had no symptoms after the first dose. The day of the second dose, she experienced migraine auras: seeing things that aren't there. She saw black dots and had dizziness. She never develops a headache. She has been evaluated by her doctor and her eyes are fine. This is not a new thing for her since she experiences migraine auras once or twice a year. Her doctor heard this has been experienced in other patients and thought she should report it. The outcome of event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
i experienced a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (i experienced a sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (i experienced a sore arm). At the time of the report, MYALGIA (i experienced a sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment information was not provided.
Pt recvd vax 1DEC92 & had a dec LOC; pt slept for almost 12 hrs following vax; pt was feeding but apparently not well; pt's father could not determine if pt was dehydrated; MD felt exp was related to vax;
flu like symptoms; "went down for a day"; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and MALAISE ("went down for a day") in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J202A and 025J20214) for COVID-19 vaccination.     The patient's past medical history included Heart attack (no recent change was observed in its status) on 14-Jul-2014. Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (ASPIRINE) from 14-Jul-2014 to an unknown date, ATORVASTATIN CALCIUM (LIPITOR) and CARVEDILOL (COREG) for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and MALAISE ("went down for a day"). On 27-Jan-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) and MALAISE ("went down for a day") had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.  Allergies to food, medications and other products were none.   This case was linked to MOD-2021-307592 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: significant Follow up was received which has updated patient's demographics: start date of medical history; revised date of dose 1; anatomical location; provided start date and dose information of concomitant medications.
After 2nd COVID-19 vaccination I experienced the following: a. Abdominal pains - lasted approximately 2 mos b. Thumb and middle finger of right hand developed osteoarthritis. I  presently continue to be seen by my doctor and occupational therapist.
Vaccinee is a 56 yo physician (ER doc), re-vaccinee who received vaccine on 3/4/03; some itching otherwise no initial complaints, major reaction read on 3/11/03 He developed mild headache, sweats on evening of 3/16.  Noted pleuritic chest pain, tachycadia (110), PVCs, myalgias, arthralgias.  Had mild cough slightly productive, fatigue.  Worked despite fatigue and symptoms 3/17. 3/18 noted dyspnea upon exertion and continued myalgias. Began to improve 3/19 and was much better 3/20.  Happened to be at CDC for a meeting when the health alert came out and when back in MN went to ER for w/u.  Had EKG which revealed borderline first degree AV block (PR interval of 214 ms) Also low R waves in anterior leads. ECHO by his report: very small amount of pericardial fluid, larger space so seemed to be resolving fluid.  Normal EF. CXR- atelectasis left base. ESR of 1, CRP of < 0.5, CK-MB and troponin I were not elevated. He now feels fine. He plans to get f/u EKG. PMH: no cardiac does have labile hypertension. Meds: lipitor, adacan HCL weight 310 pounds.
I am a runner and after getting flu shot I started having wheezing and shortness of breath. I ran Oct. of 2012, but after flu shot could not even run a mile without having to stop and get breath. Maybe it was not the flu shot but quite a coincident.  I am still on Symbicort inhaler.
Conjunctival swelling bilaterally - Loratadine 10 mg daily #30  right arm-15 min induration/25mm erythema, warm to touch - ice pack left arm-0mm induration/30mm erythema, warm to touch-ice pack.
Twenty minutes after vaccination, a senile purpura appeared on the top of my right wrist.  The top layers of skin in the purpura had split and were bleeding.  Within an hour of vaccination, another senile purpura opened on my right arm.  I was vaccinated on my right arm.  The second one, the top layers eventually peeled back and came off.  Senile purpura also appeared in the following days wherever adhesive bandages met the skin.  There were zero senile purpura on my left arm.
Patient reports swelling, heat and pain at injection site hours after receiving vaccine. Trying BENADRYL and ice.
pt. c/o itchness on most part of her body.  pt. doesn't want to take any benadryl.  she states that it's resolving.
Fever at onset for 3 1/2 days, vomiting on 3rd day, followed by rash (red dots all over body) on 3rd and 4th day (presently).
Patient called 10/4/09 received flu and pneumonia shot in same arm on same day-OTUC-arm is a bad arm. Is having no use moving arm now.
runny nose 8MAR95; 24MAR95 high fever, sl ear infect; t103.8; broke out in rash all over body;
Low grade temp x 2 days. Then rash & itchy x 2 days deep soreness in spine 3 wks to present no treatment need at this time.
Complaint of pain immediately with flu vaccine administration. Pain shot down arm to finger-tips. Eased some but the by the time patient got home, pain returned with nausea. Pain persisted x 4 days. Patient used Tylenol, Ultram, Heat cold massage. Had swelling in neck and arm on and off. Saw MD who advised to report. Pain eased on 5th day but still has not resolved. Also noted a "pulling" sensation in shoulder like muscle spasm.
MOM STATES PT BROKE OUT IN HIVES ALL OVER BODY, GAVE BENADRYL WITH SOME RELIEF.
Patient was given an expired vaccine on moderna on 04/03/2023 that expired 04/01/2023. Patient was notified and is feeling well, advise patient to return in 4 weeks to restart covid vaccine primary series.
Case number PHEH2015US021242, is an initial spontaneous report from a pharmacist received on 19 Oct 2015. This report refers to a 38 years old female patient. Medical history and concomitant medications were not reported. The patient was not allergic to eggs and had FLUVIRIN (batch number: not reported) in the past. The patient was vaccinated with FLUVIRIN (batch number: not reported) on an unknown date. Post vaccination the patient developed warmth and circle mark at the injection site. The outcome, seriousness and causality of the event were not reported.
Information has been received from a physician concerning a 73 year old female with no allergies or past medical history who on Nov 22 2005 was vaccinated with 0.5ml pneumococcal 23v polysaccharide vaccine. Concomitant therapy included alendronate sodium (MSD), loratadine (Claritin), minerals (unspecified) (+) vitamins (unspecified), (OCUVITE), polyethylene glycol 3350 (Miralax) and fexofenadine hydrochloride (Allergra). On Nov 23 2005, the day after the patient was vaccinated, the patient developed swelling and severe inflammation. The physician reported that the patient was seen in his office and presented with some redness below the injection site on her right arm which the physician felt was some type of allergic type reaction. The physician reported that apparently the reaction worsened and the patient was seen in the ER where she was treated with IV methylprednisolone sodium succinate (SoluMedrol). possibly azithromycin (Zithromax) and a tapering dose of prednisone (previously reported as treated with doxycycline and a shot of prednisone and then released). The physician reported that they thought it was cellulitis. The physician reported that the patient's swelling, erythema and inflammation were serious and required intervention to prevent further serious side effects (OMIC). The physician reported that the patient was recovering as of Nov 29 2005 and that he would follow up with her to monitor her progress. Additional information has been requested.
The patients did not experience any symptoms; patient was vaccinated with improperly stored varivax; This spontaneous report as received from a medical assistant refers to a 4 year old female patient. The patient's pertinent medical history and drug reactions or allergies were not reported. The patient's concomitant therapy included sterile diluent. On 22-JAN-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis (strength, dose, route of administration and anatomical location were not reported) of lot # S006647 is an invalid lot number, expiry date reported as 05-MAR-2021 for prophylaxis (product storage error). The patient did not experience any symptoms. The outcome of product storage error was unknown. The temperature excursion for varicella virus vaccine live (oka/merck) (VARIVAX) was reported as -9 degrees Celsius (C) to 8 degrees Celsius (3.3 C) for 53 hours. There was no previous temperature excursion reported. Data logger was involved. No product quality complaint (PQC) was associated with this report.  This is one of the multiple reports from the same reporter.; Sender's Comments:  US-009507513-1911USA011629: